Intracardiac thrombosis associated with a pacemaker lead in a patient with antiphospholipid syndrome

Authors

  • Marina Povar Echeverría Internal Medicine Service. Miguel Servet University Hospital, Zaragoza
  • Gabriel Hurtado Rodríguez Cardiology Service. Miguel Servet University Hospital, Zaragoza
  • Eva María Moreno Esteban Echocardiography section. Cardiology Service. Miguel Servet University Hospital, Zaragoza
  • Pablo Esteban Auquilla Clavijo Cardiology Service. San Jorge University Hospital, Huesca.

DOI:

https://doi.org/10.37615/retic.v5n1a8

Keywords:

intracardiac thrombus, transthoracic echocardiography, transesophageal echocardiography.

Abstract

We introduce the case of a patient with a dual-chamber permanent pacemaker who was admitted because of an initial diagnosis of pulmonary thromboembolism. In the CT scan a filling defect in the right atrium (RA) was detected. A transthoracic echocardiogram was performed and a large mobile mass was observed in the RA attached to the atrial pacemaker lead compatible with thrombus due to its characteristics and location. The presence of antiphospholipid syndrome was detected as a predisposing prothrombotic cause. Medical treatment with indefinite
anticoagulation was chosen due to the clinical stability of the patient.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm. 2011;8:1622-8.

Udo EO, Zuithoff NP, Van Hemel NM, De Cock CC, Hendriks T, Doevendans PA et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728-35.

European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070-1118.

Van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol. 2004;15:1258–62.

Silva Marques J, Varela MG, Ferreira R, Nobre A, Almeida AG, de Sousa J. Intracardiac sterile pacemaker lead thrombosis. Rev Esp Cardiol (Engl Ed). 2012 Feb;65(2):193-4. English, Spanish.

Carda R, Almería C, Lennie V, Serra V, Zamorano JL. What to do with an atrial thrombus? Eur J Echocardiogr. 2008 Jan;9(1):204-5.

D’Aloia A, Bonadei I, Vizzardi E, Curnis A. Right giant atrial thrombosis and pulmonary embolism complicating pacemaker leads. BMJ Case Rep. 2013;2013:bcr2012008017.

Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol. 2002;25:1301–6.

Published

2022-04-30

How to Cite

1.
Povar Echeverría M, Hurtado Rodríguez G, Moreno Esteban EM, Auquilla Clavijo PE. Intracardiac thrombosis associated with a pacemaker lead in a patient with antiphospholipid syndrome. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2022 Apr. 30 [cited 2024 Dec. 22];5(1):37-40. Available from: https://imagenretic.org/RevEcocarPract/article/view/431